Global buccal drug delivery system market size was valued at USD 2.86 billion in 2021 and is expected to reach USD 6.31 Billion by 2030, growing at a CAGR of 9.6% during the forecast period.
Polaris Market Research recently published [115+ Pages] research report on “Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis Report, By Type (Sublingual Films, Buccal Tablets, and Lozenges, Oral Sprays); By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others); By End-Use (Hospitals, Ambulatory Centers, Others), By Region; Segment Forecast, 2022 – 2030” in its research database.
According to the research report, the global buccal drug delivery system market size was valued at USD 2.86 billion in 2021 and is expected to reach USD 6.31 Billion by 2030, growing at a CAGR of 9.6% during the forecast period.
What are Buccal Drug Delivery Systems? How Big is Buccal Drug Delivery System Market?
Buccal drug delivery is a therapeutic technique for oral drug delivery in which the drug is administrated by the buccal mucosa of the oral cavity. The drug is mainly placed between the upper gums and cheeks while treating several diseases or disorders. The advantage of this method is that the removal of the left tablet from the patient’s mouth is easy if there is an unfavorable reaction.
Moreover, the buccal drug delivery system includes the rapid absorption of the desired therapeutic dose of the drug into plasma, and the stability of this absorption is preserved during the overall treatment. The increasing predilection of macromolecules that includes absorption enhancers, peptides, and other related molecules is uplifting the buccal drug delivery system market share. Also, the rising convenience of non-ionized drugs is propelling the market.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/buccal-drug-delivery-system-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Key Highlights of the Report
Some of the Top Market Players Are:
To Know Additional Information on Market Players, Download Sample PDF Brochure
Growth Driving Factors
The buccal drug delivery system market demand is rising due to drug administration and termination, ease in the growing use of smaller molecules, availability of blood vessels, and immediate immersion of drugs into plasma. The rapid rise in the existence of leading competitors in the medication distribution system market and the availability of pharmaceuticals is anticipated to boost the industry over the assessment period.
Furthermore, rapid absorption, fewer biofluid interaction, fewer side effects, favorable concentration availability at the target site, and a smaller treatment regimen are the factors accelerating the buccal drug delivery system market size. Also, as the number of chronic disease cases is rising across the globe, the requirement for buccal drug administration has increased rapidly. The growing adoption rate of novel healthcare technologies is fuelling the market growth.
Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/12341
Recent Developments by
Segmental Analysis
On the basis of product type, the buccal tablets and lozenges segment is considered the largest market share. The factors responsible for the segment’s dominance are cost-effectiveness, consumer acceptance, ease of formulation, and the huge availability of medication candidates for formulation. Also, the sublingual film segment is anticipated to dominate the market over the assessment period owing to the fast availability of large concentrations of medication at a target site and substantial research into evolving controlled-release formulations.
Based on application, the buccal drug delivery system market segmentations are classified into several segments. Out of all the smoking cessation segments accounted for the highest market share. The responsible factors for the segment’s dominance are treating the addicted people from nicotine or smoking. A buccal medication delivery system is the most preferred and effective method. Nicotine lozenges are more beneficial at delivering a more significant absorption of the medication than gums or other dosage forms.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/buccal-drug-delivery-system-market/inquire-before-buying
(Inquire about a report quote OR available discount offers to the sales team before purchase.)
Buccal Drug Delivery System Market: Report Scope
| Report Attribute | Details |
| Market Outlook for 2030 | USD 6.31 Billion |
| Market Size 2021 Value | USD 2.86 Billion |
| Expected CAGR Growth | 9.6% from 2022 – 2030 |
| Base Year | 2021 |
| Forecast Year | 2022 – 2030 |
| Top Market Players | Applied Pharma Research, ARDEA BIOSCIENCES LIMITED, ARx LLC, AstraZeneca, Bayer AG, BioDelivery Sciences International, Inc., Catalent, Cynapsus Therapeutics Inc., Dr. Reddy’s Laboratories Ltd, Endo Pharmaceuticals plc, F. Hoffmann-La Roche Ltd, Generex Biotechnology, GlaxoSmithKline plc, Indivior PLC, MedLab, NAPP PHARMACEUTICALS LIMITED, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi, Takeda Pharmaceutical Company Limited., and Teva Pharmaceutical Industries Ltd |
| Segments Covered | By Type, By Application, By End-Use, By Region |
| Customization Options | Customized purchase options are available to meet your research needs. Explore customized purchase options |
Geographic Overview
On a geographical basis, the North American region is considered to have the highest buccal drug delivery system market share and is anticipated to maintain its dominance over the foreseen period. This is due to evolved pharmaceutical sector. Also, the factors driving the regional market are the existence of a large number of market players, increased research to identify suitable drug candidates, significant investment by leading players to enhance the development of innovative formulations, and improved detection and treatment rates.
Further, Asia Pacific is expected to boost the industry over the assessment period due to development in the pharmaceutical industry. Also, the rapid rise in the senior population, the pharmaceutical industry’s development, and a substantial increase in domestic players are the other factors anticipated to boost the regional market growth.
Browse the Detail Report “Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis Report, By Type (Sublingual Films, Buccal Tablets, and Lozenges, Oral Sprays); By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others); By End-Use (Hospitals, Ambulatory Centers, Others), By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/buccal-drug-delivery-system-market
For Additional Information OR Media Enquiry, Please Mail Us At: sales@polarismarketresearch.com
Key Questions Answered in The Report Include:
Polaris Market Research has segmented the buccal drug delivery system market report based on type, application, end-user, and region:
By Type Outlook
By Application Outlook
By End Use Outlook
By Region Outlook
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals.
Buccal Drug Delivery System Market , Buccal Drug Delivery System Market Analysis , Buccal Drug Delivery System Market Growth , Buccal Drug Delivery System Market Research , Buccal Drug Delivery System Market Share , Buccal Drug Delivery System Market Size
Jan 22, 2023
Copyright © 2006 - 2023 PRnob Media, UBIC Solutions, LLC. All Rights Reserved.
